Softcare Limited

As of December 31, 2025, Softcare Limited carries a market capitalization of 20.04B, placing it among publicly traded companies globally. Its enterprise value stands at 16.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Softcare Limited's next confirmed earnings release is scheduled for March 22, 2027.

As of December 31, 2025, Softcare Limited has 619.52M shares outstanding.

As of December 31, 2025, Softcare Limited trades at a trailing price-to-earnings ratio of 18.07. The price-to-sales ratio is 3.86, and the price-to-book ratio stands at 4.04.

As of December 31, 2025, Softcare Limited trades at an EV/EBITDA multiple of 14.48 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.79 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.57 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Softcare Limited trades at an EV/FCF ratio of 33.46, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 16.73B versus a market cap of 20.04B, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Softcare Limited maintains a current ratio of 5.69, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.33, indicating elevated leverage, while an interest coverage ratio of 104.31 demonstrates strong ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. The company generates approximately 1.52M in revenue per employee across its workforce of 2,906.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended December 31, 2025, Softcare Limited recorded 182.92M in income tax expense. That works out to an effective tax rate of 16.25, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.13B, leaving 942.89M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026. The 50-day moving average sits at 29.42, while the 200-day moving average is 29.83.

Over the twelve months ended December 31, 2025, Softcare Limited generated 4.42B in revenue and converted that into 942.89M in net income, yielding earnings per share of 1.79. EBITDA reached 1.16B, while operating income came in at 1.11B.

As of December 31, 2025, Softcare Limited holds 3.47B in cash and equivalents against 165.12M in total debt, resulting in a net debt position of -3.36B. Total book value stands at 4.96B, with working capital of 4.04B providing operational flexibility.

Softcare Limited produced 898.32M in operating cash flow over the twelve months ended December 31, 2025. After subtracting -407.56M in capital expenditures, free cash flow totaled 490.76M - equivalent to 0.93 per share.

Over the twelve months ended December 31, 2025, Softcare Limited posted a gross margin of 35.87, reflecting its pricing power and cost economics. The operating margin of 25.24 and net profit margin of 21.35 provide insight into operational efficiency.

Over the twelve months ended December 31, 2025, Softcare Limited paid dividends of 0.52 per share. The dividend payout ratio of 28.89 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 2.87, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -13.40, meaning Softcare Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of December 31, 2025, Softcare Limited has an Altman Z-Score of 14.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.